Loading...
Gene Editing Royalties And Slow Adoption Will Pressure Results Yet Support Long Term Upside
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
-74.3%7D
-7.9%1Y
-74.3%7D
-7.9%You can edit this narrative until Jan 12 2:05 AM. Then, changes will post as Updates.